Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon

BACKGROUND: The cause and clinical significance of the transient decrease in platelet (PLT) count observed in relapsing remitting multiple sclerosis (RRMS) during alemtuzumab administration remain undefined. The aim of this study was to analyse the kinetics and clinical relevance of early onset thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Puthenparampil, Marco, Rinaldi, Francesca, Federle, Lisa, Cazzola, Chiara, Perini, Paola, Gallo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784536/
https://www.ncbi.nlm.nih.gov/pubmed/29399047
http://dx.doi.org/10.1177/1756285617741056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784536/
https://www.ncbi.nlm.nih.gov/pubmed/29399047
http://dx.doi.org/10.1177/1756285617741056

Ejemplares similares